ArticleScientific reports2023
Photocatalytic degradation of tetracycline antibiotics by RGO-CdTe composite with enhanced apparent quantum efficiency.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Aluminum-doped gallium sulfide shell for enhancing the luminescence properties of Ag-In-Ga-S core quantum dots and their composite for dye adsorption.RSC advances · 2026Article
- Reduced graphene oxide promoted by SnOScientific reports · 2025Article
- Photocatalytic degradation of tetracycline from aqueous solution with graphene oxide and hydroxyapatite composites.Scientific reports · 2025Article
- BiFeRSC advances · 2025Article
- MoSScientific reports · 2024Article
- Review
- Stepwise reduction of graphene oxide and studies on defect-controlled physical properties.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RGO-CdTe composite was synthesized using a straightforward, easy-to-realize, one-pot solvothermal technique. The synthesized composite was characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), Brunauer-Emmett-Teller method (BET), Raman spectra, UV-Vis absorption, and photoluminescence measurement. The RGO-CdTe composite exhibited 83.6% photocatalytic degradation efficiency for the aqueous tetracycline (TC) antibiotic solution and the apparent quantum yield (AQY) for the same was as high as 22.29% which is 2.63 times higher than that of CdTe. The scavenger investigation demonstrated that although hole acts as the leading active species, despite that, superoxide and hydroxyl radicals have also played crucial roles. The initial pH-dependent photocatalytic performance was measured. The zeta potential of the composite at different pH values was evaluated to establish the photocatalytic performance of the RGO-CdTe towards TC degradation at different pH. The recycling experiment depicts that only a 10% degradation performance declines after 5 times recycle use of the RGO-CdTe photocatalyst. An efficient photocurrent generation in RGO-CdTe thin film device has also been observed. Our study establishes as-synthesized composite of RGO-CdTe as a highly potential, and stable photocatalyst for the degradation of antibiotics from the polluted aqueous environment with a very good photoinduced charge generation efficiency in its solid phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.